Acetazolamide Therapy for Metabolic Alkalosis in Pediatric Intensive Care Patients*

Abstract

Acetazolamide decreases serum HCO3 and PCO2 in PICU cardiac patients with metabolic alkalosis secondary to diuretic therapy. Cardiac postoperative patients present a significant increase in urine output after acetazolamide treatment.